Milan Apotica SRL
Milan Apotica reported total assets of 321,144 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Milan Apotica shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -93 % Total assets +27 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Milan Apotica's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 15 Jun 2022
Milan Apotica's financial analysis
- Solvency2.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Milan Apotica
Milan Apotica's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0841.722.547
- VAT number
- BE0841722547
- Peppol
- Registered · 0208:0841722547 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Dec 2011
- Registered office
- 1410 Waterloo
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Milan Apotica (SRL) has been based in Waterloo since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 709 € and equity of 8,407 €; its revenue is not published. Its solvency stands at 2.6%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Milan Apotica
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie du Quartier Breughel Retail sale of pharmaceutical products Brussels · balance sheet 311,272 €
- Apotheek Tanghe - Vanneste Retail sale of pharmaceutical products Pajottegem · balance sheet 318,191 €
- Vision 2017 Retail sale of pharmaceutical products Schaerbeek · balance sheet 318,760 €
- Somapi Retail sale of pharmaceutical products Liège · balance sheet 317,064 €
- Verapharm Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 327,020 €
- Medi Falcon Retail sale of pharmaceutical products Aalst · balance sheet 328,898 €
- An Brebels Retail sale of pharmaceutical products Oudsbergen · balance sheet 313,168 €
- Geassocieerde Apotheek Ekeren Retail sale of pharmaceutical products Antwerp · balance sheet 331,202 €
Frequently asked questions about Milan Apotica
What is the revenue of Milan Apotica?
Milan Apotica files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Milan Apotica?
In Belgium, the VAT number is the company number prefixed with BE: BE0841722547 for Milan Apotica, if the company is VAT-registered. Its company number (CBE) is 0841.722.547.
Where is the registered office of Milan Apotica?
According to the CBE register, the registered office of Milan Apotica is in 1410 Waterloo.
What is the equity of Milan Apotica?
At the close of the 2025 financial year, the equity of Milan Apotica amounts to 8,407 €, a solvency of 2.6% of total assets.
Who manages Milan Apotica?
The register lists 1 active mandates at Milan Apotica. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Milan Apotica
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →